JP2005179193A - Vegetable antitumor agent - Google Patents

Vegetable antitumor agent Download PDF

Info

Publication number
JP2005179193A
JP2005179193A JP2003418222A JP2003418222A JP2005179193A JP 2005179193 A JP2005179193 A JP 2005179193A JP 2003418222 A JP2003418222 A JP 2003418222A JP 2003418222 A JP2003418222 A JP 2003418222A JP 2005179193 A JP2005179193 A JP 2005179193A
Authority
JP
Japan
Prior art keywords
plant
extract
dry powder
antitumor agent
turmeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003418222A
Other languages
Japanese (ja)
Inventor
Kensaku Gushiken
健作 具志堅
Yukari Ikehara
ゆかり 池原
Kaori Hachi
香織 羽地
Takeshi Miyagi
健 宮城
Keiichi Sadoyama
恵一 佐渡山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OKINAWA HAKKO KAGAKU KK
Original Assignee
OKINAWA HAKKO KAGAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OKINAWA HAKKO KAGAKU KK filed Critical OKINAWA HAKKO KAGAKU KK
Priority to JP2003418222A priority Critical patent/JP2005179193A/en
Publication of JP2005179193A publication Critical patent/JP2005179193A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To find out a new vegetable antitumor agent and to provide a food additive and a healthy food comprising a new vegetable antitumor ingredient. <P>SOLUTION: The antitumor agent, food additive and healthy food comprise dried powder of at least one or more species of plant bodies selected from the group consisting of Artemisia campestris L., Limonium wrightii O. kuntze and Peucedanum japonicum Thunb. or an extract therefrom as an active ingredient. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、癌の予防及び治療に有用な植物起源の抗腫瘍剤、食品添加物及び健康食品に関する。   The present invention relates to an antitumor agent of plant origin, food additive and health food useful for the prevention and treatment of cancer.

現在、抗腫瘍活性、発癌抑制活性、腫瘍細胞増殖抑制活性等の作用を有する種々の植物が知られており、抗癌剤(抗腫瘍剤、制癌剤とも呼ばれる)、癌の予防用の健康食品等として広く用いられている。   Currently, various plants having actions such as antitumor activity, carcinogenesis-inhibiting activity, tumor cell growth-inhibiting activity are known, and are widely used as anticancer agents (also called antitumor agents, anticancer agents), health foods for cancer prevention, etc. It is used.

例えば、特許文献1には、ヨモギ、ヨモギの水抽出物、ウーロン茶の水抽出物、番茶の水抽出物、シソ及びシソの水抽出物が、癌の予防及び治療に有効であることが記載されている。   For example, Patent Document 1 describes that mugwort, mugwort water extract, oolong tea water extract, bancha water extract, perilla and perilla water extract are effective for the prevention and treatment of cancer. ing.

また、抗癌作用機序はそれぞれ異なっているが、例えば、グアバ(特許文献2)、ニガウリ(特許文献3)、ウコン(特許文献4)、ユーカリ(特許文献5)などにも抗癌作用があることが記載されている。   In addition, although the anticancer action mechanisms are different from each other, for example, guava (Patent Document 2), bitter gourd (Patent Document 3), turmeric (Patent Document 4), eucalyptus (Patent Document 5) and the like have anticancer effects. It is described that there is.

特開平8−3054号公報JP-A-8-3054 特開平7−291873号公報JP-A-7-291873 特開2002−205953号公報JP 2002-205953 A 特開2002−136267号公報JP 2002-136267 A 特開2002−306139号公報JP 2002-306139 A

本発明は、新規な植物性抗腫瘍剤を見出すことを目的とする。   An object of the present invention is to find a novel plant antitumor agent.

さらに、本発明は、新規な植物性抗腫瘍性成分を含む食品添加物及び健康食品を提供することを目的とする。   Furthermore, an object of this invention is to provide the food additive and health food containing a novel plant antitumor component.

上記目的を達成するため、本発明者らは鋭意研究を重ね、沖縄県に生育する琉球ヨモギ、ボタンボウフウ及びウコンイソマツに抗腫瘍活性が有ることを見出し、本発明を完成させた。   In order to achieve the above-mentioned object, the present inventors have conducted intensive research and found that Ryukyu mugwort, button bowfish and turmeric islet have an antitumor activity and have completed the present invention.

すなわち、本発明は、
(1)琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を有効成分とする抗腫瘍剤;
(2)植物の乾燥粉末の抽出物が、水又はエタノールで抽出したものであることを特徴とする、上記(1)に記載の抗腫瘍剤;
(3)琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を含む食品添加物;及び
(4)琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を含む健康食品
を提供する。
That is, the present invention
(1) An antitumor agent comprising, as an active ingredient, a dry powder of at least one plant selected from the group consisting of Ryukyu mugwort, turmeric pine, and button-brow fu or an extract thereof;
(2) The antitumor agent according to (1) above, wherein the plant dry powder extract is extracted with water or ethanol;
(3) A food additive containing at least one plant dry powder selected from the group consisting of Ryukyu mugwort, turmeric pine, and button humor or an extract thereof; and (4) Ryukyu mugwort, turmeric pine and button humor. A health food containing a dry powder of at least one plant selected from the group consisting of or an extract thereof is provided.

本発明によれば、新規な植物性抗腫瘍剤、食品添加物及び健康食品が提供される。   According to the present invention, a novel plant antitumor agent, food additive, and health food are provided.

本発明の植物性抗腫瘍剤、食品添加物及び健康食品を摂取することにより、癌を予防及び治療することができる。   By ingesting the plant antitumor agent, food additive and health food of the present invention, cancer can be prevented and treated.

以下、本発明を詳細に説明する。
本発明の抗腫瘍剤、食品添加物及び健康食品は、琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を有効成分とする。
Hereinafter, the present invention will be described in detail.
The antitumor agent, food additive, and health food of the present invention contain at least one dry powder of plant selected from the group consisting of Ryukyu mugwort, turmeric pine, and button-blow fuchu or an extract thereof as an active ingredient.

琉球ヨモギ(Artemisa campestris L.)は、キク科の植物であり、インチングサ、ハママーチ等の方言名で呼ばれることもある。主として沖縄県の久米島、慶良間島、奥武島等の海岸に生育する低木状の多年生草木である。琉球ヨモギは、扁桃腺炎、黄疸、疸石、糖尿病、腎臓病などに有効であることが知られている(「おきなわの薬草百科」、多和田真淳・大田文子共著)。   Ryukyu mugwort (Artemisa campestris L.) is a plant belonging to the family Asteraceae and is sometimes called by dialect names such as Inchingsa and Hama March. This shrub-like perennial plant grows mainly on the coasts of Okinawa Prefecture such as Kumejima, Keramajima, and Okutakejima. Ryukyu mugwort is known to be effective for tonsillitis, jaundice, meteorites, diabetes, kidney disease, etc. ("Okinawa's medicinal herb encyclopedia", co-authored by Shingo Tawada and Fumiko Ota).

ボタンボウフウ(Peucedanum japonicum Thanb.)は、セリ科の植物であり、サクナ、チョーミーグサ等の方言名で呼ばれることもある。主として沖縄県の海岸の岩石地、砂礫地等に自生する強壮で常緑の3年生草木であり、海辺の陽当たり良い地に生え、高さ90cm位に達し、茎は自立して分枝する。ボタンボウフウは、高血圧、動脈硬化、神経痛、リュウマチ、肋膜炎、咳、喘息、百日咳、解熱などに有効であることが知られている(「おきなわの薬草百科」、多和田真淳・大田文子共著)。   Button bowfish (Peucedanum japonicum Thanb.) Is a plant belonging to the family Aceraceae and is sometimes called by dialect names such as sacna and chomyusa. It is a strong and evergreen three-year-old vegetation that grows naturally on rocky and gravel grounds on the coast of Okinawa Prefecture. It grows in a sunny place on the seaside, reaches a height of about 90 cm, and its stems branch independently. Buttonbow is known to be effective for hypertension, arteriosclerosis, neuralgia, rheumatism, pleurisy, cough, asthma, whooping cough, antipyretic, etc. ("Okinawa Herbal Encyclopedia", Shingo Tawada and Fumiko Ota).

ウコンイソマツ(Limoniom wrightii O. kuntze)は、イソマツ科の植物であり、ガラサムパン、ウミマーチ、テンムグサ等の方言名で呼ばれることもある。主として沖縄本島の南部及び架橋のある島、宮古島、伊良部、下地、池間島、八重山の石垣・竹富町波照間島、与那国島の、海水に浸るか海水のかかる石の上に自生する。ウコンイソマツは、肝臓病、腎臓病、糖尿病、神経痛、風邪などに有効であり、下げ薬としても有用であることが知られている(「沖縄民俗薬用動植物誌」、ニライ社)。   Turmeric pine (Limoniom wrightii O. kuntze) is a plant belonging to the family Pinaceae, and is sometimes called by dialect names such as galamsam bread, sea urchin, and cypress. It grows naturally on stones that are immersed in seawater or seawater on the southern part of the main island of Okinawa, Miyakojima, Irabu, Shimobe, Ikejima, Yaeyama Ishigaki, Taketomicho Haterumajima, Yonagunijima. Turmeric pine is effective for liver disease, kidney disease, diabetes, neuralgia, cold, etc., and is also known to be useful as a lowering drug ("Okinawa folk medicinal animals and plants", Nirai).

本発明において、「植物体」とは、上記3種の植物の茎、葉などの地上部及び根部を意味する。   In the present invention, the “plant” means the above-ground part and root part of the above three kinds of plants such as stems and leaves.

植物体の乾燥粉末の製造方法は特に限定されず、当業界で通常用いられる方法を採用することができ、例えば、図1に示す工程で製造することができる。植物の有用な部分を採取し、水洗し、適当な長さ(1〜15cm程度)に切断し、50〜70℃の温風乾燥機で、8時間程度乾燥させた後、ソーゴ式粉砕機(相互産業社製)を用いて粉砕することによって植物体の乾燥粉末(粒度0.8mm Pass程度)を得る。   The manufacturing method of the dry powder of a plant body is not specifically limited, The method normally used in this industry is employable, For example, it can manufacture in the process shown in FIG. A useful part of the plant is collected, washed with water, cut into an appropriate length (about 1 to 15 cm), dried with a hot air dryer at 50 to 70 ° C. for about 8 hours, and then a sogo type grinder ( A dry powder (particle size of about 0.8 mm Pass) is obtained by pulverizing using a mutual industry company.

植物体の乾燥粉末は、1種の植物体のみから製造した単独の乾燥粉末としてもよいし、複数の植物体を混合したものから製造した混合乾燥粉末としてもよい。   The dry powder of the plant may be a single dry powder produced from only one kind of plant, or a mixed dry powder produced from a mixture of a plurality of plants.

植物体の乾燥粉末の抽出物の製造方法も特に限定されず、当業界で通常用いられる方法を採用することができ、例えば、図2に示す抽出工程を用いることができる。抽出に用いる溶媒としては、当業界で通常用いられるもの、例えば、水、エタノール等のアルコール類が好ましい。   The method for producing the extract of the dry powder of the plant body is not particularly limited, and a method usually used in the art can be adopted. For example, the extraction step shown in FIG. 2 can be used. As a solvent used for extraction, those usually used in the art, for example, alcohols such as water and ethanol are preferable.

植物体乾燥粉末の抽出物は、溶液、スラリー、乾燥粉末等の性状をとりうる。   The plant dry powder extract can have properties such as a solution, slurry, and dry powder.

上記図1の工程で得られた乾燥粉末を水抽出する場合には、例えば、図2に示すように、乾燥粉末100gに、500〜1500mL(5〜15倍量)の水を加え、室温〜90℃の温度で、昇温後15〜120分かけて成分を抽出し、遠心分離後、濾過(ADVANTEC社製濾紙No5C等を使用)して乾燥粉末の抽出残渣を除去し、水抽出液Iを得る。
上記乾燥粉末の抽出残渣に、500〜2000mL(2〜5倍量)の水を加え、さらに、上記と同様にして成分を抽出し、遠心分離後、濾過して乾燥粉末の抽出残渣を除去し、水抽出液IIを得る。ここでの抽出残渣は廃棄する。
When the dry powder obtained in the step of FIG. 1 is extracted with water, for example, as shown in FIG. 2, 500 to 1500 mL (5 to 15 times amount) of water is added to 100 g of the dry powder, and the room temperature to At 90 ° C., the components were extracted for 15 to 120 minutes after the temperature was raised, centrifuged, and filtered (using ADVANTEC filter paper No5C, etc.) to remove the dry powder extraction residue, and water extract I Get.
Add 500-2000 mL (2-5 volumes) of water to the dry powder extract residue, extract the components in the same way as above, centrifuge and filter to remove dry powder extract residue. A water extract II is obtained. The extraction residue here is discarded.

上記水抽出液I及びIIを併せ、ロータリーエバポレーター(SHIMAZU社製)で、固形量が10〜20%(10〜20g/100g)程度になるまで減圧濃縮し、殺菌する。ここへ、必要に応じて、賦形剤(例えば、デキストリン等)を添加(10%の減圧濃縮物であれば0〜30g;20%の減圧濃縮物であれば0〜60g)し、スプレードライ又は凍結乾燥することにより、粉末状の水抽出物製品を得る。水抽出物の収量は、植物の種類により、琉球ヨモギの場合で植物体水抽出物の乾燥粉末100gから、通常17〜23g(収率17〜23%)、ウコンイソマツの場合で通常7〜12g(収率:7〜12%)、ボタンボウフウの場合で通常23〜30g(収率:23〜30%)程度である。   The above water extracts I and II are combined and concentrated under reduced pressure using a rotary evaporator (manufactured by SHIMAZU) until the solid content is about 10 to 20% (10 to 20 g / 100 g). If necessary, an excipient (for example, dextrin, etc.) is added (0-30 g for a 10% vacuum concentrate; 0-60 g for a 20% vacuum concentrate) and spray dried. Alternatively, a powdery water extract product is obtained by freeze-drying. The yield of water extract is usually 17-23 g (yield 17-23%) from dry powder 100 g of plant water extract in the case of Ryukyu mugwort, and 7-12 g in the case of turmeric pine, depending on the type of plant. (Yield: 7 to 12%), usually about 23 to 30 g (yield: 23 to 30%) in the case of button-up.

また、エタノール抽出する場合には、図3に示すように、例えば、乾燥粉末100gに、500〜1500mL(5〜15倍量)のエタノールを加え、室温〜70℃の温度で、昇温後15〜120分かけて成分を抽出し、遠心分離後、濾過して乾燥粉末の抽出残渣を除去し、エタノール抽出液Iを得る。   In the case of ethanol extraction, as shown in FIG. 3, for example, 500 to 1500 mL (5 to 15 times the amount) of ethanol is added to 100 g of dry powder, and the temperature is increased from room temperature to 70 ° C. The components are extracted over ˜120 minutes, centrifuged, and then filtered to remove the dry powder extraction residue to obtain the ethanol extract I.

上記乾燥粉末の抽出残渣に、500〜2000mL(2〜5倍量)のエタノールを加え、さらに、上記と同様にして成分を抽出し、遠心分離後、濾過して乾燥粉末の抽出残渣を除去し、エタノール抽出液IIを得る。ここでの抽出残渣は廃棄する。   Add 500-2000 mL (2-5 volumes) of ethanol to the dry powder extract residue, extract the components in the same manner as above, centrifuge and filter to remove dry powder extract residue. The ethanol extract II is obtained. The extraction residue here is discarded.

上記エタノール抽出液I及びIIを併せ、ロータリーエバポレーター(SHIMAZU社製)で、固形量が10〜20%(10〜20g/100g)程度になるまで減圧濃縮し、殺菌する。ここへ、必要に応じて、賦形剤(例えば、デキストリン等)を添加(10%の減圧濃縮物であれば0〜30g;20%の減圧濃縮物であれば0〜60g)し、スプレードライ又は凍結乾燥することにより、粉末状のエタノール抽出物製品を得る。エタノール抽出物の収量は、植物の種類により、琉球ヨモギの場合で植物体エタノール抽出物の乾燥粉末100gから通常17〜28g(収率17〜28%)、ウコンイソマツの場合で通常8〜12g(収率8〜12%)、ボタンボウフウの場合で通常23〜30g(収率23〜30%)程度である。   The ethanol extracts I and II are combined and concentrated under reduced pressure using a rotary evaporator (manufactured by SHIMAZU) until the solid content is about 10 to 20% (10 to 20 g / 100 g). If necessary, an excipient (for example, dextrin, etc.) is added (0-30 g for a 10% vacuum concentrate; 0-60 g for a 20% vacuum concentrate) and spray dried. Alternatively, a powdery ethanol extract product is obtained by lyophilization. Depending on the type of plant, the yield of ethanol extract is usually 17-28 g (yield 17-28%) from 100 g of dry powder of plant ethanol extract in the case of Ryukyu mugwort, and usually 8-12 g in the case of turmeric pine ( Yield: 8 to 12%), and in the case of button bow, it is usually about 23 to 30 g (yield 23 to 30%).

乾燥粉末の抽出成分は、1種の植物から得た乾燥粉末から抽出したものでもよいし、複数種の植物のそれぞれの乾燥粉末を混合したものから抽出したものでもよい。また、上記の混合乾燥粉末から抽出したものでもよい。   The extraction component of the dry powder may be extracted from a dry powder obtained from one kind of plant, or may be extracted from a mixture of dry powders of a plurality of kinds of plants. Moreover, what was extracted from said mixed dry powder may be used.

上記のようにして得られた植物体の乾燥粉末又はその抽出物は、後述する試験例に示すように、抗腫瘍活性を有し、抗腫瘍剤として利用できる。   The plant powder obtained as described above or an extract thereof has antitumor activity and can be used as an antitumor agent, as shown in Test Examples described later.

本発明の植物体の乾燥粉末を植物性抗腫瘍剤として投与する場合の投与形態としては、お茶(煎じ薬)、粉末、錠剤、顆粒、カプセルなどが挙げられる。また、植物体の乾燥粉末の抽出物の場合には、溶液、錠剤、顆粒、レトルトパウチ、カプセル等が挙げられる。これらの投与形態は、当業界で公知の手法、器具、添加剤等を用いて製造することができる。図4〜7に顆粒、錠剤、レトルトパウチ及びカプセルの製造工程を示すフロー図を示す。   Examples of the administration form when the dry powder of the plant of the present invention is administered as a plant antitumor agent include tea (decoction), powder, tablets, granules, capsules and the like. Moreover, in the case of the extract of the dry powder of a plant body, a solution, a tablet, a granule, a retort pouch, a capsule etc. are mentioned. These dosage forms can be produced using techniques, devices, additives and the like known in the art. The flowchart which shows the manufacturing process of a granule, a tablet, a retort pouch, and a capsule to FIGS. 4-7 is shown.

本発明の植物性抗腫瘍剤の投与方法としては、上記形態のものを経口投与することが好ましい。   As a method for administering the plant antitumor agent of the present invention, the above-mentioned form is preferably administered orally.

本発明の植物性抗腫瘍剤の急性毒性については、ウコンイソマツ、琉球ヨモギ、ボタンボウフウの3種類の抽出物(デキストリン等の賦形剤を添加していないもの)を、それぞれ5g/kgの投与量でマウスに経口投与し、24時間までに死亡が認められるかを観察した結果、マウスの死亡は認められず、上記3種類の抽出物のLD50は5g/kg以上であった。この数値は、体重60kgの人が一度に300gの抽出物を摂取することに相当し、人体に対する安全性は高く、経口投与での毒性は発現しないと考えられる。   As for the acute toxicity of the plant antitumor agent of the present invention, 5 g / kg of each of three types of extracts of turmeric isopine, Ryukyu mugwort, and button fountain (without addition of excipients such as dextrin) are administered. As a result of observing whether or not death was observed by 24 hours, the mice were not observed dead, and the LD50 of the above three types of extracts was 5 g / kg or more. This value corresponds to a person weighing 60 kg taking 300 g of extract at a time, and is considered to be highly safe for the human body and not to exhibit toxicity after oral administration.

本発明の植物性抗腫瘍剤は、植物の乾燥粉末又はその抽出物の抗腫瘍活性を向上させることができる追加成分として、種々の栄養成分、薬効成分等を含むことができる。   The plant antitumor agent of the present invention can contain various nutritional components, medicinal components, and the like as additional components that can improve the antitumor activity of the dried plant powder or the extract thereof.

本発明の食品添加物は、種々の食品に添加成分として加えられるものであり、種々の食品と共に摂取されて抗腫瘍活性を示す。本発明の食品添加物が添加される食品としては特に限定されないが、例えば、クッキー、麺類、清涼飲料、シリアル、スナック類、ドレッシング等が挙げられる。   The food additive of the present invention is added as an additive component to various foods, and is taken together with various foods to exhibit antitumor activity. The food to which the food additive of the present invention is added is not particularly limited, and examples thereof include cookies, noodles, soft drinks, cereals, snacks, and dressings.

本発明の健康食品は、それ自体を食品として摂取されて抗腫瘍活性を示す。本発明の健康食品は、当業界で通常用いられる方法を用いて、粉末、錠剤、カプセル等種々の形態とすることができる。   The health food of the present invention itself is ingested as a food and exhibits antitumor activity. The health food of the present invention can be made into various forms such as powders, tablets, capsules and the like using a method commonly used in the art.

本発明の抗腫瘍剤、食品添加物及び健康食品は、抗腫瘍活性を有しており、癌の予防、治療に有用である。   The antitumor agent, food additive and health food of the present invention have antitumor activity and are useful for the prevention and treatment of cancer.

以下、実施例、試験例を記載して、本発明をより具体的に説明する。   Hereinafter, the present invention will be described more specifically by describing examples and test examples.

実施例1:植物体の乾燥粉末水抽出物の製造
(1)琉球ヨモギの植物体乾燥粉末100gを、ロータリーエバポレーター(SHIMAZU社製)に入れ、水900mLを加えて、90℃まで昇温し、60分間抽出を行い、濾過して抽出残渣を除去し、琉球ヨモギの水抽出液Iを得た。上記抽出残渣に、水870mLを加え、上記と同様の条件で再度抽出を行い、琉球ヨモギの水抽出液IIを得た。得られた水抽出液I及びIIを併せ、ロータリーエバポレーターで、温度70℃で、固形量が20%程度になるまで濃縮し、凍結乾燥(EYELA社製)し、琉球ヨモギの水抽出物乾燥粉末22gを得た。
Example 1: Production of dry powder water extract of plant
(1) 100 g of dry plant powder of Ryukyu mugwort is put in a rotary evaporator (manufactured by SHIMAZU), 900 mL of water is added, the temperature is raised to 90 ° C., extraction is performed for 60 minutes, and the extraction residue is removed by filtration. An aqueous extract I of Ryukyu mugwort was obtained. 870 mL of water was added to the extraction residue, and extraction was performed again under the same conditions as above to obtain a water extract II of Ryukyu mugwort. The obtained water extracts I and II were combined, concentrated on a rotary evaporator at a temperature of 70 ° C. until the solid content reached about 20%, freeze-dried (manufactured by EYELA), and dried powder of Ryukyu mugwort water extract. 22 g was obtained.

(2)上記(1)において、抽出残渣に加える水の量を751mLとした以外は、ボタンボウフウの植物体乾燥粉末についても上記(1)と同様にして、水抽出物乾燥粉末27.5gを得た。
(3)上記(1)において、抽出残渣への水の添加量を750mLとした以外は、ウコンイソマツの植物体乾燥粉末についても上記(1)と同様にして、水抽出物乾燥粉末11.1gを得た。
(2) In the above (1), except that the amount of water added to the extraction residue was 751 mL, 27.5 g of the water extract dry powder was also obtained for the dry powder of the button bud plant as in (1) above. Obtained.
(3) In the above (1), except for the addition amount of water to the extraction residue was 750 mL, the dried turmeric plant powder was the same as the above (1) in the same manner as in the above (1). Got.

実施例2:植物体の乾燥粉末エタノール抽出物の製造
(1)琉球ヨモギの植物体乾燥粉末100gを、ロータリーエバポレーター(SHIMAZU社製)に入れ、50%エタノール900mLを加えて、70℃まで昇温し、60分間抽出を行い、濾過して抽出残渣を除去し、琉球ヨモギのエタノール抽出液Iを得た。上記抽出残渣に、50%エタノール750mLを加え、上記と同様の条件で再度抽出を行い、琉球ヨモギのエタノール抽出液IIを得た。得られたエタノール抽出液I及びIIを併せ、ロータリーエバポレーターで、温度70℃で、固形量が20%程度になるまで濃縮し、凍結乾燥し、琉球ヨモギのエタノール抽出物乾燥粉末19.5gを得た。
Example 2: Production of dry powder ethanol extract of plant body
(1) 100 g of dry plant powder of Ryukyu mugwort is put in a rotary evaporator (manufactured by SHIMAZU), 900 mL of 50% ethanol is added, the temperature is raised to 70 ° C., extraction is performed for 60 minutes, and the extraction residue is filtered. After removal, an ethanol extract I of Ryukyu mugwort was obtained. To the extraction residue, 750 mL of 50% ethanol was added, and extraction was performed again under the same conditions as above to obtain an ethanol extract II of Ryukyu mugwort. The obtained ethanol extracts I and II were combined and concentrated on a rotary evaporator at a temperature of 70 ° C. until the solid content was about 20%, and lyophilized to obtain 19.5 g of dry powder of Ryukyu mugwort ethanol extract. It was.

(2)上記(1)において、抽出残渣への50%エタノールの添加量を700mLとした以外は、ボタンボウフウについても上記(1)と同様にして、エタノール抽出物乾燥粉末23gを得た。 (2) In the above (1), except for the addition amount of 50% ethanol to the extraction residue was changed to 700 mL, 23 g of ethanol extract dry powder was obtained in the same manner as in (1) above.

(3)上記(1)において、抽出残渣への添加量を700mLとした以外は、ウコンイソマツについても上記(1)と同様にして、エタノール抽出物乾燥粉末10.3gを得た。 (3) In the same manner as in (1) above, except that the amount added to the extraction residue in the above (1) was 700 mL, 10.3 g of ethanol extract dry powder was obtained in the same manner as in (1) above.

試験例:植物体の水抽出物の抗腫瘍活性の測定
本試験は、図8に示す手順で実施した。
(1)HL−60腫瘍細胞に対する抗腫瘍活性
予め培養しておいたHL−60腫瘍細胞を、800rpmで2分間遠心し、細胞をPBS(−)で2回洗浄し、10%FCS(fetal calf serum;Biofluids社製)を加えたRPMI1640培地(Gibco社製)中で細胞濃度を調整し、細胞懸濁液を調整した。
Test Example: Measurement of anti-tumor activity of water extract of plant This test was carried out according to the procedure shown in FIG.
(1) Antitumor activity against HL-60 tumor cells Pre-cultured HL-60 tumor cells were centrifuged at 800 rpm for 2 minutes, the cells were washed twice with PBS (-), and 10% FCS (fetal calf The cell concentration was adjusted in RPMI 1640 medium (Gibco) supplemented with serum (manufactured by Biofluids) to prepare a cell suspension.

上記実施例1で製造した3種の植物体の水抽出物をPBS(−)に溶解し、それぞれ0.625、1.25、2.5、5.0及び10.0mg/mL濃度になるように細胞懸濁液に添加し、試料溶液とした。   The three plant aqueous extracts produced in Example 1 above were dissolved in PBS (−) to concentrations of 0.625, 1.25, 2.5, 5.0, and 10.0 mg / mL, respectively. Thus, it added to the cell suspension to make a sample solution.

96穴マイクロプレートに、1.0×10個/ウェルとなるように、上記細胞懸濁液180μLを播き、上記各濃度の試料溶液20μLをそれぞれ添加し、37℃、5%CO雰囲気下で3日間培養した後、2−(4−ロドフェニル9−3−(4−ニトロフェニル)−5−(2,4−ジスルホフェニル)−2H−テトラゾリウム 一ナトリウム塩(2-(4-lodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt;WST−1)と1−メトキシ−5−メチル−フェナジニウム メチル スルフェート(1-Methoxy-5-methyl-phenazinium methylsulfate;PMS)との混合溶液20μLを加え、37℃、5%CO雰囲気下で3時間培養した後、マイクロプレートミキサー(NISSIN社製)で攪拌し、マイクロプレートリーダー(Bio-TEK社製)を用い、450nmでの吸光度を測定し、腫瘍細胞の生存率を求めた。結果を図9のグラフに示す。 In a 96-well microplate, 180 μL of the cell suspension is seeded so as to be 1.0 × 10 4 cells / well, and 20 μL of the sample solution with each concentration is added, respectively, at 37 ° C. in a 5% CO 2 atmosphere. After culturing for 3 days, 2- (4-Lodophenyl 9-3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium monosodium salt (2- (4-lodophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium, monosodium salt; WST-1) and 1-methoxy-5-methyl-phenazinium methyl sulfate (1-Methoxy-5-methyl) After adding 20 μL of a mixed solution with -phenazinium methylsulfate (PMS) and culturing at 37 ° C. in a 5% CO 2 atmosphere for 3 hours, the mixture was stirred with a microplate mixer (manufactured by NISSIN), and a microplate reader (Bio-TEK) Made at 450 nm The intensity was measured to determine the survival rate of tumor cells. The results are shown in the graph of FIG.

図9の結果から、琉球ヨモギ、ボタンボウフウ及びウコンイソマツの植物体の水抽出物は、抗腫瘍活性を有することが明らかとなった。   From the results shown in FIG. 9, it was revealed that the water extract of Ryukyu mugwort, button-brow fu, and turmeric pine plants had antitumor activity.

ウコンイソマツは、0.625mg/mLの低い添加量でHL−60腫瘍細胞を20%以下まで抑制でき、さらに1.25mg/mLの添加量で10%以下まで強力に抑制できることがわかる。   It can be seen that turmeric pine can suppress HL-60 tumor cells to 20% or less with a low addition amount of 0.625 mg / mL, and can further strongly suppress to 10% or less with an addition amount of 1.25 mg / mL.

琉球ヨモギも、1.25mg/mLの低い添加量でHL−60腫瘍細胞を約20%まで抑制でき、さらに2.5mg/mLの添加量で約10%以下まで強力に抑制できることがわかる。   It can be seen that Ryukyu mugwort can also suppress HL-60 tumor cells to about 20% at a low addition amount of 1.25 mg / mL, and can further strongly suppress to about 10% or less at an addition amount of 2.5 mg / mL.

ボタンボウフウについては、10.0mg/mLの添加量では、HL−60腫瘍細胞を約10%まで強力に抑制できるが、5mg/mL以下の添加量では、HL−60腫瘍細胞の生存率は逆に増加していることを示す結果となった。添加量5.0mg/mL以下の濃度で吸光度が上昇した理由は不明である。   For button fountains, HL-60 tumor cells can be strongly suppressed to about 10% at an addition amount of 10.0 mg / mL, but at an addition amount of 5 mg / mL or less, the survival rate of HL-60 tumor cells is reversed. The result showed that the number of The reason why the absorbance increased at a concentration of 5.0 mg / mL or less is unknown.

(2)K−562腫瘍細胞に対する抗腫瘍活性
用いた腫瘍細胞をK−562に変えた以外は上記(1)と同様にしてK−562腫瘍細胞に対する抗腫瘍活性を測定した。結果を図10のグラフに示す。
(2) Antitumor activity against K-562 tumor cells Antitumor activity against K-562 tumor cells was measured in the same manner as in (1) above except that the used tumor cells were changed to K-562. The results are shown in the graph of FIG.

図10の結果から、琉球ヨモギは、0.625mg/mLの低い添加量でK−562腫瘍細胞を約40%まで抑制することができ、1.25mg/mLの添加量では10%以下まで強力に抑制できることがわかる。   From the results of FIG. 10, Ryukyu mugwort can suppress K-562 tumor cells to about 40% at a low addition amount of 0.625 mg / mL, and is strong up to 10% or less at an addition amount of 1.25 mg / mL. It can be seen that it can be suppressed.

ウコンイソマツは、0.625mg/mLの低い添加量でK−562腫瘍細胞を10%以下まで強力に抑制できることがわかる。   It can be seen that turmeric pine can strongly suppress K-562 tumor cells to 10% or less with a low addition amount of 0.625 mg / mL.

ボタンボウフウについては、10.0mg/mLの添加量では、K−562腫瘍細胞を約10%まで強力に抑制できるが、5.0mg/mL以下の添加量では、K−562腫瘍細胞の生存率は逆に増加していることを示す結果となった。この理由も、HL−60腫瘍細胞について述べたのと同様である。   For button fountains, K-562 tumor cells can be strongly suppressed to about 10% at an addition amount of 10.0 mg / mL, but the survival rate of K-562 tumor cells at an addition amount of 5.0 mg / mL or less. On the other hand, the results showed that it increased. The reason for this is the same as described for the HL-60 tumor cells.

本発明によって、新たな植物性抗腫瘍剤、食品添加物及び健康食品が提供された。   According to the present invention, new plant antitumor agents, food additives and health foods are provided.

図1は、植物体乾燥粉末の製造工程を示すフロー図である。FIG. 1 is a flowchart showing a process for producing a plant dry powder. 図2は、植物体乾燥粉末の水抽出物の製造工程を示すフロー図である。FIG. 2 is a flowchart showing a process for producing a water extract of a dry plant powder. 図3は、植物体乾燥粉末のエタノール抽出物の製造工程を示すフロー図である。FIG. 3 is a flow chart showing a production process of an ethanol extract of a dry plant powder. 図4は、植物体の乾燥粉末又はその抽出物の顆粒化フロー図である。FIG. 4 is a granulation flow diagram of a dry powder of a plant body or an extract thereof. 図5は、植物体の乾燥粉末又はその抽出物の錠剤化フロー図である。FIG. 5 is a tableting flow diagram of a dry powder of plant or an extract thereof. 図6は、植物体の乾燥粉末又はその抽出物のレトルトパウチ化フロー図である。FIG. 6 is a flow chart of retort pouching of a dried plant powder or an extract thereof. 図7は、植物体の乾燥粉末又はその抽出物のカプセル化フロー図である。FIG. 7 is an encapsulation flow diagram of a dried plant powder or an extract thereof. 図8は、抗腫瘍活性の測定方法の手順を示すフロー図である。FIG. 8 is a flowchart showing the procedure of the method for measuring antitumor activity. 図9は、植物体水抽出物のHL−60腫瘍細胞に対する細胞増殖抑制効果を示すグラフである。FIG. 9 is a graph showing the cell growth inhibitory effect of plant body water extract on HL-60 tumor cells. 図10は、植物体水抽出物のK−562腫瘍細胞に対する細胞増殖抑制効果を示すグラフである。FIG. 10 is a graph showing the cell growth inhibitory effect of plant body water extract on K-562 tumor cells.

Claims (4)

琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を有効成分とする抗腫瘍剤。   An antitumor agent comprising, as an active ingredient, a dry powder of at least one kind of plant selected from the group consisting of Ryukyu mugwort, turmeric pine, and button bow fu or an extract thereof. 植物の乾燥粉末の抽出物が、水又はエタノールで抽出したものであることを特徴とする、請求項1に記載の抗腫瘍剤。   The antitumor agent according to claim 1, wherein the extract of the dry powder of the plant is extracted with water or ethanol. 琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を含む食品添加物。   A food additive comprising a dry powder of at least one plant selected from the group consisting of Ryukyu mugwort, turmeric pine, and button-brow fu or an extract thereof. 琉球ヨモギ、ウコンイソマツ及びボタンボウフウからなる群から選択される少なくとも1種以上の植物体の乾燥粉末又はその抽出物を含む健康食品。   A health food comprising at least one dry powder of a plant selected from the group consisting of Ryukyu mugwort, turmeric pine, and button bow fu or an extract thereof.
JP2003418222A 2003-12-16 2003-12-16 Vegetable antitumor agent Pending JP2005179193A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003418222A JP2005179193A (en) 2003-12-16 2003-12-16 Vegetable antitumor agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003418222A JP2005179193A (en) 2003-12-16 2003-12-16 Vegetable antitumor agent

Publications (1)

Publication Number Publication Date
JP2005179193A true JP2005179193A (en) 2005-07-07

Family

ID=34780492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003418222A Pending JP2005179193A (en) 2003-12-16 2003-12-16 Vegetable antitumor agent

Country Status (1)

Country Link
JP (1) JP2005179193A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009054504A1 (en) * 2007-10-24 2009-04-30 Suntory Holdings Limited Ligand agent for peroxisome proliferator-activated receptor (ppar)
KR100965304B1 (en) * 2008-02-13 2010-06-22 재단법인 한국원자력의학원 Composition for preventing or treating a disease mediated by overexpression of heat shock protein 27
CN105852122A (en) * 2016-04-05 2016-08-17 浙江海洋学院 Limonium wrightii health-care food and processing technology thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003026694A (en) * 2001-07-17 2003-01-29 Tetsuya Toyokawa Disaccharide-degrading enzyme inhibitor
JP2003119117A (en) * 2001-10-15 2003-04-23 Maruzen Pharmaceut Co Ltd Anticariogenic agent and composition for oral cavity
JP2003137799A (en) * 2001-03-28 2003-05-14 Kiyotoshi Oshiro Diacylglycerol solution including turmeric and method for producing the same
JP2003174857A (en) * 2002-12-04 2003-06-24 Fancl Corp Food composition
JP2004359732A (en) * 2003-06-02 2004-12-24 Ryukyu Bio Resource Kaihatsu:Kk Antioxidant

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003137799A (en) * 2001-03-28 2003-05-14 Kiyotoshi Oshiro Diacylglycerol solution including turmeric and method for producing the same
JP2003026694A (en) * 2001-07-17 2003-01-29 Tetsuya Toyokawa Disaccharide-degrading enzyme inhibitor
JP2003119117A (en) * 2001-10-15 2003-04-23 Maruzen Pharmaceut Co Ltd Anticariogenic agent and composition for oral cavity
JP2003174857A (en) * 2002-12-04 2003-06-24 Fancl Corp Food composition
JP2004359732A (en) * 2003-06-02 2004-12-24 Ryukyu Bio Resource Kaihatsu:Kk Antioxidant

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009054504A1 (en) * 2007-10-24 2009-04-30 Suntory Holdings Limited Ligand agent for peroxisome proliferator-activated receptor (ppar)
KR100965304B1 (en) * 2008-02-13 2010-06-22 재단법인 한국원자력의학원 Composition for preventing or treating a disease mediated by overexpression of heat shock protein 27
CN105852122A (en) * 2016-04-05 2016-08-17 浙江海洋学院 Limonium wrightii health-care food and processing technology thereof

Similar Documents

Publication Publication Date Title
Willcox Improved traditional phytomedicines in current use for the clinical treatment of malaria
JP4393777B2 (en) Anti-Helicobacter pylori composition
JP6656316B2 (en) How to use cucumbers, how to use cucumbers extract and how to use drug mixtures
Nyeem et al. Solanum nigrum (Maku): A review of pharmacological activities and clinical effects
KR101396458B1 (en) A food or drink composition comprising fermented eastern prickly pear
KR102607602B1 (en) Synergistic composition for osteoarthritis
JP7020915B2 (en) Soluble and stable pharmaceutical compositions that are anti-inflammatory, proliferative, protective and mucosal adherent, their use and acquisition methods for treating the condition of mucosal sites, and basic pharmaceutical compositions for the preparation of pharmaceutical compositions. Things and how to get them
KR102085774B1 (en) Pharmaceutical composition for prevention or treatment of colon cancer
JP2005179193A (en) Vegetable antitumor agent
KR101470603B1 (en) Manufacturing method of herbextract for removing harmful elements caused by smoking
Goshwami et al. In-vitro evaluation of anthelmintic activity of Lasia spinosa leaves
KR100195503B1 (en) Seaweed pills made of seadweed solid and extract
KR20160098571A (en) COMPOSITION COMPRISING EXTRACT OF Carex scabrifolia Steud HAVING ANTI-INFLAMMATORY AND ANTI-OXIDANT ACTIVITY
KR101769774B1 (en) Health functional food for preventing or treatment tumor
CN116782893A (en) Composition for preventing, improving or treating gastritis or peptic ulcer comprising cinnamon extract, fraction of said extract, isolate of said fraction or compound isolated therefrom
WO2002032440A1 (en) Murraya koenigii extracts for treating asthma
AU2001235968A1 (en) Murraya koenigii extracts for treating asthma
KR20180082921A (en) Composition for preventing or treating gastritis or peptic ulcer
JP2006225297A (en) Agent for treating/preventing obesity, hyperlipemia and arteriosclerotic disease
KR20180065419A (en) Composition for anti-inflammation with nipa fruticans wurmb
KR101528557B1 (en) A pharmaceutical composition comprising fermented Eastern prickly pear
KR20190119020A (en) A composition for anti-inflammation comprising hemistepta lyrata extract
KR20160082568A (en) Composition comprising Rhus verniciflua for extraction and extraction mthod of the Composition
JPWO2005056031A1 (en) Lipase inhibitor
TWI654986B (en) Use of extraction mixture in preparing pharmaceutical composition for reducing triglyceride production

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100615

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101019